Revance Therapeutics Inc (RVNC): Well, looks like RVNC is giving me yet a...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	32
Posts	4325
Boards Moderated	0
Alias Born	07/25/2007

vinmantoo

Re: None

Friday, 05/10/2024 1:12:37 PM

Friday, May 10, 2024 1:12:37 PM

Well, looks like RVNC is giving me yet another opportunity for selling to generate a tax loss. I would prefer they stop doing that already. Sheeesh.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RVNC News

Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:12:12 PM
Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 11/07/2024 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 01:24:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2024 01:29:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 11:32:37 AM
Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm • PR Newswire (US) • 09/27/2024 01:17:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:15:36 AM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/16/2024 09:01:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:06:45 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 09/05/2024 09:27:28 PM
Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 09/05/2024 08:45:25 PM
Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 08/13/2024 01:29:06 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/12/2024 09:18:26 PM
Rowley Law PLLC is Investigating Proposed Acquisition of Revance Therapeutics, Inc. • PR Newswire (US) • 08/12/2024 07:18:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:20:58 PM
Crown Laboratories and Revance Announce Entry Into Merger Agreement • PR Newswire (US) • 08/12/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 01:00:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:34:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:07:57 PM
Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 08/08/2024 08:05:00 PM
Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • Business Wire • 08/01/2024 08:05:00 PM
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM

More RVNC News

InvestorsHub NewsWire

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover